Triple-negative breast cancer (TNBC) is, among all breast cancer subtypes, the most immunogenic (6–8), presenting with higher T cell infiltration, mutational burden, and PD-L1 expression (9, 10); however, when compared to other tumor subtypes, TNBC is considered a “cold” tumor (11–13). This evidence concerns the gene CD274 and neoplasm.